Artículos científicos Open Access
Dido Harding: the former business leader now heading up England’s covid-19 response
The BMJ
Gareth Iacobucci
Covid-19: does the UK spend a large enough proportion of its national wealth on the provision of healthcare?
The BMJ
Stephen T Green, Lorenzo Cladi
Registering ethnicity for covid-19 research: is the law an obstacle?
The BMJ
Corrette Ploem, Jeanine Suurmond
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Signal Transduction and Targeted Therapy
Lee, W., Ahn, J.H., Park, H.H. et al.
COVID-19 must catalyse changes to clinical development
Nature Reviews Drug Discovery
Rod MacKenzie, et al
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
Nature Medicine
Tostanoski, L.H., Wegmann, F., Martinot, A.J. et al
Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
Cell Discovery
Zang, J., Gu, C., Zhou, B. et al.
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Signal Transduction and Targeted Therapy volume
Chen, X., Pan, Z., Yue, S. et al.
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
Modern Pathology
Borczuk, A.C., Salvatore, S.P., Seshan, S.V. et al.
